Discover 517 paid clinical trials in Cedar Rapids, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 517
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Iowa City IA, Chicago IL, Franklin TN, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07109219
Phase 1, Phase 2, Recruiting
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
for
Multiple Myeloma
Location: Iowa City IA, St Louis MO, Nashville TN, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07073547
Phase 1, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Iowa City IA, Davenport IA, Springfield IL,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Iowa City IA, West Des Moines IA, Rockford IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
Detection of Cannabis Impairment With ISBRG's SpotLight-THC
for
Cannabis
Location: Iowa City IA
Sponsor: ISBRG Corp
Sex: All
Age: 18+
Code: NCT05276232
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Progressive Achilles Loading Via Clinician E-support
A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Iowa City IA
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 12 - 17
Code: NCT07700758
Phase 2, Recruiting
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
for
Solid Tumor
Location: Iowa City IA, Edgewood KY, Pittsburgh PA, Phoenix AZ
Sponsor: Oxford BioTherapeutics Ltd
Sex: All
Age: 18+
Code: NCT04064359
Phase 1, Recruiting
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)